Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation

Status: Completed
Location: See all (11) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY

ROSTRA is an international, prospective, non-randomized, single-arm, multi-center, and post-market study to collect real-world safety and effectiveness data on Abbott's IonicRF™Generator and compatible RFA accessories. This post-market study is intended to satisfy EU MDR requirements.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ A. All candidate subjects

• Subject must provide written informed consent prior to any clinical investigation-related procedure

• Subject is ≥ 18 years of age

• Subject has chronic pain \> 6 months and was unresponsive to conservative management

• Subject has pain on an NRS scale of ≥ 6

• Subject is scheduled for an RFA procedure with the IonicRF generator within 30 days of baseline to treat chronic pain at one anatomical region

• Subject has stable chronic pain medication use for 30 days

• Subject is willing and able to comply with the prescribed follow-up evaluations

⁃ B. Candidate subjects with facet joint pain (lumbar or cervical)

• Subject has unilateral or bilateral pain on para-spinal palpation and localized pain with extension/lateral bending

• Subject has facet joint pain confirmed by at least 1 positive medial branch block with 0.5 mL or less of anesthetics (across at least 3 vertebral levels) achieving at least 50% pain relief, with real-time injection of radiographic contrast under fluoroscopic guidance

⁃ C. Candidate subjects with sacroiliac joint pain

• Subject has sacroiliac joint pain based on medical history and physical exam

• Subject has sacroiliac joint pain confirmed by an infiltration of local anesthetics in the posterior part of the sacroiliac joint achieving at least 50% pain relief

⁃ D. Candidate subjects with radicular pain

• Subject has radicular pain based on medical history and physical exam

• Subject has radicular pain confirmed by dermatomal mapping corresponding to at least 1 nerve root level

⁃ E. Candidate subjects with trigeminal neuralgia

• Subject has trigeminal pain based on medical history and physical exam

• Subject did not have any mass effect or stroke causing trigeminal pain confirmed by MRI

• Subject is ≥ 60 years of age in case of a neurovascular conflict

⁃ F. Candidate subjects with knee or hip pain

• Subject has knee or hip pain based on medical history and physical exam

• Subject has radiographically confirmed osteoarthritis of the hip or knee, or has chronic pain following joint arthroplasty

Locations
United States
Minnesota
Nura
Edina
Nevada
Nevada Advanced Pain Specialists
Reno
New York
Ainsworth Institute of Pain Management
New York
West Virginia
The Spine & Nerve Center of St Francis Hospital
Charleston
Other Locations
Belgium
AZ Delta vzw
Roeselare
France
Hôpital Privé du Confluent
Nantes
Germany
Universitätsmedizin Berlin - Charité Campus Mitte
Berlin
Krankenhaus Neuwerk Maria von den Aposteln
Monchengladbach
Netherlands
Stichting Rijnstate Ziekenhuis - Arnhem
Arnhem
Spain
Hospital Puerta del Mar
Cadiz
Hospital Clínico Universitario de Valencia
Valencia
Time Frame
Start Date: 2021-06-29
Completion Date: 2023-03-08
Participants
Target number of participants: 184
Treatments
IonicRF Generator and compatible accessories
IonicRF Radiofrequency Generator, along with any country-specific market-released accessory (i.e. electrode, cannula, grounding pad, and adaptor cable) compatible with the IonicRF Generator will be used.
Sponsors
Leads: Abbott Medical Devices

This content was sourced from clinicaltrials.gov